Regeneron to treat coronavirus patients this week in trial using its rheumatoid arthritis drug
Regeneron Pharmaceuticals this week initiated test trials of an arthritis drug as a potential remedy for the worst symptoms of COVID-19 in hopes of confirming studies in China. CNBC
No comments:
Post a Comment